Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
N/A
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
8004-92-0
Name of the chemical
1H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts (CI 47005) (35), (36)
Concentration
N/A
EC/CAS
232-679-6
Name of the chemical
Starch
Concentration
N/A
EC/CAS
238-877-9
Name of the chemical
Talc: Hydrated magnesium silicate
Concentration
N/A
EC/CAS
240-474-8
Name of the chemical
Disodium 2-(2,4,5,7-tetraiodo-6-oxido-3-oxoxanthen-9-yl)benzoate and its insoluble barium, strontium and zirconium lakes, salts and pigments
Concentration
N/A
General Information
Revision date
2006-12-15
Product name
DEPRANCOL
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Inc
GHS Information
Signal word
DANGER
Section 2
SECTION 2: Hazards identification
Appearance: Capsules
Signal word
DANGER
Hazard statements
Toxic if swallowed. May cause central nervous system effects
Additional information
Known Clinical Effects: Clinical use of this drug has caused sleepiness (somnolence), nausea, vomiting, dizziness. Cases of severe overdose may lead to respiratory depression, mental confusion, coma, seizure. EU Indication of danger: Toxic EU Hazard Symbols: EU Risk Phrases: R25 - Toxic if swallowed. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
